Showing results (491-500 of 794) with videos related to
Sort By:
Pageof 80
Radiology|September 6, 2022
Photon-counting Detector CT with Deep Learning Noise Reduction to Detect Multiple MyelomaFrancis I Baffour, Nathan R Huber, Andrea Ferrero, et al.Transplantation and Cellular Therapy|April 10, 2021
Prognostic Implications of Rising Serum Monoclonal Protein and Free Light Chains after Autologous Stem Cell Transplantation in Patients with Multiple MyelomaHarsh Parmar, Abdullah S Al Saleh, Alissa Visram, et al.British Journal of Haematology|November 29, 2024
Autologous stem cell transplantation for multiple myeloma patients whose myeloma-defining event was SLiMIuliana Vaxman, Shaji Kumar, Inbar Cohen, et al.Oncogene|March 1, 2005
Molecular characterization of PS-341 (bortezomib) resistance: implications for overcoming resistance using lysophosphatidic acid acyltransferase (LPAAT)-beta inhibitorsTeru Hideshima, Dharminder Chauhan, Kenji Ishitsuka, et al.Blood|June 16, 2011
Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myelomaSumit Madan, Martha Q Lacy, Angela Dispenzieri, et al.Science Signaling|November 19, 2009
Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growthTaro Hitosugi, Sumin Kang, Matthew G Vander Heiden, et al.British Journal of Haematology|July 6, 2017
Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT-2 follow-up and post-hoc analyses on progression-free survival and tumour growthMeletios A Dimopoulos, Sagar Lonial, Darrell White, et al.Blood|September 29, 2012
Sequence analysis of β-subunit genes of the 20S proteasome in patients with relapsed multiple myeloma treated with bortezomib or dexamethasoneDavid I Lichter, Hadi Danaee, Michael D Pickard, et al.Biorxiv : the Preprint Server for Biology|January 30, 2023
Human Bone Marrow Plasma Cell Atlas: Maturation and Survival Pathways Unraveled by Single Cell AnalysesMeixue Duan, Doan C Nguyen, Chester J Joyner, et al.Biomaterials|December 22, 2024
Multi-niche human bone marrow on-a-chip for studying the interactions of adoptive CAR-T cell therapies with multiple myelomaDelta Ghoshal, Ingrid Petersen, Rachel Ringquist, et al.Pageof 80